Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeOur CompanyOur societal impact Global Health Equity It’s time to end drug-resistant tuberculosis: The case for action
      Dr. Anna Vassall of the London School of Hygiene & Tropical Medicine discussing the "The Cost of Complacency", a 2019 report from the Economist Intelligence Unit

      It’s time to end drug-resistant tuberculosis: The case for action

      Share Article
      share to

      A new report published by The Economist Intelligence Unit (EIU), and with support from Johnson & Johnson, emphasizes the urgent need for focused global action to address the growing threat of DR-TB. Through innovative partnerships and collaborations, Johnson & Johnson is working to create world without DR-TB and end TB.

      Learn more about the report here.

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.